© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Sydney Jennings
Articles
Hormone Therapy and Autoimmune Disease Risk in Postmenopausal Women, With Xuezhi Daniel Jiang, MD, PhD
October 27, 2025
TMS 2025: Jiang explains why he investigated hormone therapy's effect on autoimmune disease risk in postmenopausal women.
AI-Powered Diabetes Prevention Program Intervention Matches Human Coaching in Landmark Trial
October 27, 2025
After 1 year of coaching by the AI app or a DPP-associated coach, reductions in weight and HbA1c and increases in physical activity were equal, an outcome with great promise for scalability.
Estetrol Phase 3 Trial Shows No Impact on Postmenopausal BP, Even in Women at High CV Risk
October 27, 2025
The phase 3 E4COMFORT II trial found no impact on BP after 1 year of treatment in postmenopausal women with elevated HbA1c, lipids, and TGs.
Caroline Mitchell, MD, Describes Toll of Genitourinary Syndrome of Menopause on QoL
October 27, 2025
TMS: Half of postmenopausal women suffer from GSM, yet only 25% seek treatment. Mitchell, an expert in vulvovaginal health, explains the gap and its impact on women.
FDA Green-Lights Elinzanetant, First Dual NK-1/NK-3 Antagonist, for Moderate to Severe Vasomotor Symptoms of Menopause
October 24, 2025
The novel once-daily nonhormonal therapy offers a new option to offer women who prefer not to take HRT or for whom it is contraindicated.
Marla Shapiro, CM, MDCM, on Recognizing Early Perimenopause: Sleep, Mood, and Other Missed Clues
October 24, 2025
Subtle sleep, mood, and cycle changes may herald perimenopause. Dr. Marla Shapiro discusses how clinicians can recognize and address them early.
Menopause Education Lags in Residency Training Across Primary Care Specialties
October 24, 2025
Less than one-third of residents in IM, FM, and OB/GYN programs receive structured menopause training, leaving many unprepared for midlife women’s care.
Timing of Menopausal Hormone Therapy May Impact Biomarkers of Alzheimer Disease
October 24, 2025
A secondary analysis of the ELITE trial suggests that there may be a postmenopausal "critical window" during which use of MHT is optimal.
Menopause Education Wholly Inadequate for Physician Associates, According to New Survey Results
October 23, 2025
Only 3% of physician associate respondents reported receiving more than 5 hours of menopause-related training during their professional education.
Treating Hot Flashes May Improve Cognitive Symptoms: Study Author Explains the Connection
October 23, 2025
TMS 2025: Katrina Wugalter, MA, explains why treating vasomotor symptoms may be key to improving cognitive function during menopause.